Resources

Phase 2 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils, Trail, BC (Final)

Phase 2 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils (2000)

This report covers the second phase studying whether the lead in Trail soils could be rendered less available to children by adding something to reduce its solubility in the human gastrointestinal tract. Learn how the second set of bench-scale trials using phosphate, iron and pulp mill organic residual were conducted, and what the results suggested.

Phase 2 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils (2000) Read More »

HHRA: Phase 3 Screening-level deterministic risk calculations revised (2000)

HHRA Phase 3: Screening-Level Deterministic Risk Calculations, Revised (2000)

Learn whether substances other than lead pose a potential concern in Trail. This phase further evaluates risks associated with arsenic and cadmium, incorporating new data from air and indoor dust monitoring. The potential for adverse health effects from long-term residence in Trail was limited. Continued monitoring of air concentrations for arsenic and cadmium was recommended.

HHRA Phase 3: Screening-Level Deterministic Risk Calculations, Revised (2000) Read More »

Phase 3 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils, Trail, BC 

Phase 3 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils (1999 – Draft)

This report covers the third phase of work to study whether the lead in Trail soils could be rendered less available to children by adding something to reduce its solubility in the human gastrointestinal tract. Learn how the third set of trials using phosphate, iron and other potential amendments were conducted, and what results suggested.

Phase 3 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils (1999 – Draft) Read More »

HHRA: Phase 2: Screening-level deterministic risk calculations (1998)

HHRA: Phase 2: Screening-level deterministic risk calculations (1998)

Learn about whether any substances other than lead pose a potential concern in Trail. This phase eliminated five metals from further evaluation Risks from arsenic and cadmium were found to be low, but recommendations were made for further data collection and risk analysis for these remaining two metals of potential concern.

HHRA: Phase 2: Screening-level deterministic risk calculations (1998) Read More »

Phase 1 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils (1997)

This report covers the first phase of work to study whether the lead in Trail soils could be rendered less available to children by adding something to reduce its solubility in the human gastrointestinal tract. Learn how the first bench-scale trials using phosphate were conducted, and what the results suggested.

Phase 1 Investigation: In Situ Reduction of Lead Bioaccessibility in Soils (1997) Read More »

Scroll to Top